Immunology and Microbiology
Blood Level
100%
Dose Response
100%
EC50
100%
Liquid Chromatography Tandem Mass Spectrometry
100%
Pharmacodynamics
100%
Pharmacokinetics
100%
Vein
100%
Keyphrases
Anti-factor Xa
10%
Anti-Xa Activity
30%
Apixaban
100%
Clinical Utility
10%
Commercial Test
10%
Common Complications
10%
Crossover Design
10%
Deep Vein Thrombosis
10%
Dose-response Model
10%
EC50
10%
Healthy Horses
10%
Intravenous Administration
10%
Large Vessel
10%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
10%
Low Oral Bioavailability
10%
Maximum Permissible Concentration
20%
Microvascular Thrombi
10%
Oral Administration
40%
Oral Bioavailability
10%
Oral Factor Xa Inhibitors
10%
Orally Administered
10%
Patient Morbidity
10%
Patient Mortality
10%
Pharmacodynamics
100%
Pharmacokinetics
100%
Serum Concentration
10%
Pharmacology, Toxicology and Pharmaceutical Science
Apixaban
100%
Bioavailability
20%
Blood Clotting Factor 10a
10%
Blood Clotting Factor 10a Inhibitor
10%
Deep Vein Thrombosis
10%
EC50
10%
Pharmacodynamics
100%
Pharmacokinetics
100%
Thrombus
10%
Veterinary Science and Veterinary Medicine
Deep Vein
100%
Thrombus
100%